Julie P Connor

Acceptance and commitment therapy for episodic migraine: Rationale and design of a pilot randomized controlled trial.

Contemporary Clinical Trials October 2022 Carolyn Ann Bernstein, Julie P Connor, Eric S Vilsmark et al.

Migraine is a debilitating disorder with limited pharmacological options. Many migraine medications can have intolerable side effects leading patients to seek complementary and integrative health (CIM) approaches for treatment. One option that is growing in popularity and evidence is Acceptance and Commitment Therapy (ACT), a mindfulness-based therapy. The purpose of this paper is to describe...